Oct 9, 2018 | PASS Advisory
Read the full article by Laurie McGinley at washingtonpost.com The Food and Drug Administration expanded its approval of the HPV vaccine to include men and women between 27 and 45, an effort to protect more people from several types of cancer caused by the human...
Aug 30, 2018 | PASS Advisory, Press Releases
All first-generation retests have now returned negative. FSC-PASS medical professionals have determined that the production hold can be lifted, and production can resume today. Based on the testing results, there was no transmission on a PASS set, and there is no...
Aug 29, 2018 | PASS Advisory, Press Releases
We have now received the majority of first-generation tests from the individuals who had contact — on-set or off-set — with the reactive performer. So far, these tests have all come back negative. We are still waiting on results for several contacts who retested late...
Aug 28, 2018 | PASS Advisory, Press Releases
The preliminary test result from this weekend has now been confirmed as a positive. While no additional positive tests have surfaced, the production hold has been extended through Wednesday, August 29, while we complete partner retests. We hope to have retested all...
Aug 27, 2018 | PASS Advisory, Press Releases
The possibly affected performer has retested today, and we expect to have conclusive results tomorrow. In the meantime, we are working to connect the performer to health services should the test be positive. We have contacted any first-generation partners who might...
Aug 26, 2018 | PASS Advisory, Press Releases
The Free Speech Coalition is calling for a precautionary production hold after a possible positive test for HIV by an adult performer listed in the PASS database. The performer will be retested tomorrow morning, and we will know whether or not it is a false positive...
